Study at a glance
How are vitamin D boundaries and targets used?
This page explains how vitamin D blood levels are used in healthcare and research. It discusses evidence and guidelines rather than reporting one new experiment. A threshold is a boundary used to classify a result or decide whether action is needed. A target is the level that treatment or research aims to reach. These numbers can serve different purposes.
How can a vitamin D boundary change who is labelled deficient?
Using a higher boundary labels more people as having low vitamin D, even if nobody’s blood level changes. In research, the boundary also affects who enters a trial and how participants are grouped. A benefit limited to people with severe deficiency may be harder to detect in a group that includes many people with enough vitamin D. However, a higher boundary does not automatically identify people who will benefit.
Why are exact vitamin D boundaries uncertain?
People just above and below a chosen boundary may be similar in how their bodies work. Differences between laboratory tests can also change someone’s category without a meaningful change in their body. Researchers who try many boundaries after seeing their results may find a pattern that does not appear again in other research.
Does the evidence establish one vitamin D target for everyone?
The page describes how guidelines have used different boundaries for different purposes. It notes that, in 2024, the Endocrine Society stopped endorsing 30 ng/mL as a universal definition of sufficient vitamin D for generally healthy people. A blood-level target needs evidence that reaching it produces meaningful benefit. This discussion does not establish one treatment target for everyone.
Read the full article below ↓The difference between a vitamin D threshold and a vitamin D target affects clinical classification, treatment decisions, prevalence estimates and research interpretation. A threshold marks a boundary used for a defined purpose. A target is a concentration or range that clinicians or researchers intend to achieve. Treating them as equivalent can make the evidence appear more precise than it is. This summary develops the framework in Vitamin D Thresholds vs Targets. For the complete evidence treatment, see Clinical and Research Implications of Vitamin D Thresholds Versus Targets: Full Study.
Different cut-offs create different clinical populations
If 20 ng/mL is treated as a population adequacy boundary while another framework uses 30 ng/mL as the lower edge of sufficiency, the number of people classified as having low vitamin D status can change dramatically even though the biological distribution has not changed. The higher target therefore changes the apparent scale of the problem.
This is why numerical categories in Vitamin D Deficiency Definitions must be interpreted according to the question they were designed to answer.
Research results depend on where thresholds are placed
Trials may recruit participants below a threshold, divide participants into baseline-status groups or search for treatment effects within subgroups. Those choices can influence the apparent benefit of supplementation. A treatment effect concentrated in severe deficiency can be diluted in a broadly sufficient population, but choosing a higher cut-off does not automatically identify a genuinely responsive biological subgroup.
Because 25(OH)D is continuous, people immediately above and below an arbitrary boundary may be physiologically similar. Post hoc searching across multiple cut-offs can also produce apparently important thresholds that are not reproducible.
Measurement variation makes sharp targets difficult to defend
Assay standardisation studies have shown that measurement differences can materially change the apparent prevalence of low vitamin D status. When one concentration is treated as a sharp universal target, relatively small analytical differences can move an individual from one category to another without a meaningful change in physiology.
This is one reason Why Vitamin D Insufficiency Is Not a Universal Cut-Off treats intermediate status cautiously.
Guideline disagreement can reflect different questions
The Institute of Medicine used a population skeletal-health framework and concluded that 20 ng/mL would meet the needs of nearly all individuals under its model. The 2011 Endocrine Society guideline used a different clinical framework and promoted 30 ng/mL as a sufficiency boundary. In 2024, after reviewing newer randomised evidence, the Endocrine Society stopped endorsing that universal 30 ng/mL definition for generally healthy people because available trials did not establish outcome-specific 25(OH)D thresholds predicting benefit.
The change demonstrates that a target is an evidence-dependent clinical construct rather than a permanent biological fact.
The useful question is what decision the number controls
A concentration may be used as a deficiency boundary, a population adequacy value, a research classification or a treatment target. These roles should be distinguished. Population Reference Ranges Explained shows why population distributions cannot automatically be converted into individual targets.
The central implication is simple: a threshold determines when concern or action is justified; a target determines where clinicians or researchers intend the biomarker to end up. A target therefore requires direct evidence that reaching it provides additional meaningful benefit.
Scientific sources
Ross AC, Manson JE, Abrams SA, et al. The 2011 Report on Dietary Reference Intakes for Calcium and Vitamin D from the Institute of Medicine: What Clinicians Need to Know. Journal of Clinical Endocrinology & Metabolism. 2011;96(1):53-58. PMID: 21118827. PMCID: PMC3046611. DOI: 10.1210/jc.2010-2704.
Sempos CT, Heijboer AC, Bikle DD, et al. Vitamin D assays and the definition of hypovitaminosis D: results from the First International Conference on Controversies in Vitamin D. British Journal of Clinical Pharmacology. 2018;84(10):2194-2207. DOI: 10.1111/bcp.13652.
McCartney CR, McDonnell ME, Corrigan MD, Lash RW. Vitamin D Insufficiency and Epistemic Humility: An Endocrine Society Guideline Communication. Journal of Clinical Endocrinology & Metabolism. 2024;109(8):1948-1954. DOI: 10.1210/clinem/dgae322.
Related reading
Physiological Limitations of Vitamin D Deficiency Cut-Offs and Diagnostic Thresholds: Full Study
Review the physiological limitations of vitamin D deficiency cutoffs, including PTH, calcium intake, assay variation and individual biological differences.
Read more →Physiological Limitations of Vitamin D Deficiency Cut-Offs and Diagnostic Thresholds: Study Summary
A concise evidence summary explaining why vitamin D diagnostic thresholds cannot function as identical biological boundaries for every individual.
Read more →Diverse Effects of Combinations of Maternal-Neonatal VDR Polymorphisms and 25-Hydroxyvitamin D Concentrations on Neonatal Birth Anthropometry: Functional Phenocopy Variability Dependence, Highlights the Need for Targeted Maternal 25-Hydroxyvitamin D Cut-Offs during Pregnancy
The aim of this study was to evaluate the combined effect of maternal and neonatal VDR polymorphisms (ApaI, TaqI, BsmI, FokI, Tru9I) and different maternal and neonatal 25(OH)D cut-offs on neonatal birth anthropometry.
Original paper ↗Read more →Sex-Specific Cut-Offs of Single Point Insulin Sensitivity Estimator (SPISE) in Predicting Metabolic Syndrome in the Arab Adolescents
The present study aimed to assess for the first time, the validity of SPISE in predicting MetS among Arab adolescents.
Original paper ↗Read more →Why Vitamin D Deficiency Cut-Offs Differ Between Guidelines
Understand why vitamin D deficiency cutoffs differ between guidelines, including differences in outcomes, populations, evidence frameworks and clinical purpose.
Read more →Dysnatremia and Endocrine Alterations in Hospitalized COVID-19 Patients: Markers of Systemic Stress Rather than Independent Predictors of Outcomes
COVID-19 is a multisystem disorder associated with inflammatory, metabolic, electrolyte, and endocrine disturbances.
Original paper ↗Read more →Clinical and Research Implications of Vitamin D Thresholds Versus Targets: Full Study
Examine how treating vitamin D thresholds as targets affects clinical interpretation, research classification, guideline comparisons and conclusions about 25(OH)D.
Read more →Physiological Distinction Between Vitamin D Deficiency Thresholds and Functional Target Ranges: Full Study
Examine the physiological distinction between vitamin D deficiency thresholds and functional target ranges, including calcium regulation, PTH evidence and the limits of fixed cut-offs.
Read more →Physiological Distinction Between Vitamin D Deficiency Thresholds and Functional Target Ranges: Study Summary
A concise evidence summary explaining why vitamin D deficiency thresholds and functional target ranges represent different physiological and interpretive concepts.
Read more →Vitamin D Thresholds and Targets: Physiology, Clinical Meaning and Research Interpretation: Evidence Synthesis
Explore the evidence distinguishing vitamin D deficiency thresholds from functional targets and what those differences mean for clinical and research interpretation.
Read more →Vitamin D Thresholds vs Targets
Explore the difference between vitamin D thresholds and targets, why numbers vary between people, and how physiology and context shape meaningful interpretation.
Read more →Why a Vitamin D Deficiency Threshold Is Not the Same as a Functional Target
Understand why a vitamin D deficiency threshold and a functional target answer different questions and why treating them as interchangeable creates false precision.
Read more →A Narrative Review of the Evidence for Variations in Serum 25-Hydroxyvitamin D Concentration Thresholds for Optimal Health
Vitamin D3 has many important health benefits.
Original paper ↗Read more →Applying Machine Learning to Determine 25(OH)D Threshold Levels Using Data from the AMATERASU Vitamin D Supplementation Trial in Patients with Digestive Tract Cancer
Vitamin D supplementation improved 5-year relapse-free survival (RFS) compared with placebo in patients with intermediate 25(OH)D levels (18 to 28 ng/mL): vitamin D, 84% vs.
Original paper ↗Read more →Association of Vitamin D Levels and Mortality in Overactive Bladder: Nonlinear Dose-Response and Threshold Effect
This study aimed to clarify whether serum 25(OH)D levels were associated with all‐cause and cardiovascular disease (CVD) mortality in patients with OAB.
Original paper ↗Read more →C3-Epimer Inclusion Influences Vitamin D Deficiency Classification Near Diagnostic Thresholds in Early Childhood
Reclassification was strongly concentrated among children with borderline 25(OH)D3 concentrations (18 to 22 ng/mL), where 54.5% were reclassified compared with 4.2% outside this range.
Original paper ↗Read more →C3-Epimer Inclusion Influences Vitamin D Deficiency Classification Near Diagnostic Thresholds in Early Childhood
Therefore, the primary aim of this study was to assess whether inclusion of the C3-epimer affects vitamin D deficiency classification in children aged 0 to 3 years, with particular focus on concentrations near the diagnostic threshold.
Original paper ↗Read more →Serum 25-hydroxyvitamin D threshold and risk of rickets in young children: a systematic review and individual participant data meta-analysis to inform the development of dietary requirements for vitamin D
The objective of this systematic review was to determine a minimum serum 25-hydroxyvitamin D (25OHD) threshold based on the risk of having rickets in young children.
Original paper ↗Read more →Serum vitamin D as a novel biomarker for asymptomatic uterine fibroids: re-evaluating the risk threshold for incident fibroid development
This study aimed to clarify the relationship between vitamin D deficiency and first-time diagnosed asymptomatic UFs, and identify the optimal threshold for assessing the risk of newly-developed fibroids.
Original paper ↗Read more →Threshold of 25(OH)D and consequently adjusted parathyroid hormone reference intervals: data mining for relationship between vitamin D and parathyroid hormone
By recruiting reference population, we aimed to (1): estimate the 25(OH)D threshold that maximally inhibits the PTH, which can be defined as the cutoff value for vitamin D sufficiency; (2) establish the PTH reference interval (RI) in population with sufficient vitamin D.
Original paper ↗Read more →Why Vitamin D Insufficiency Is Not a Universal Cut-Off
Learn why vitamin D insufficiency has no universal numerical cut-off and how physiology, guideline purpose, population thresholds and measurement variability affect interpretation.Page type: Context.
Read more →Original sources
The 2011 Report on Dietary Reference Intakes for Calcium and Vitamin D from the Institute of Medicine: What Clinicians Need to Know
Published in Journal of Clinical Endocrinology & Metabolism (2011).
Publication details
Ross AC, Manson JE, Abrams SA, et al. The 2011 Report on Dietary Reference Intakes for Calcium and Vitamin D from the Institute of Medicine: What Clinicians Need to Know. Journal of Clinical Endocrinology & Metabolism. 2011;96(1):53-58. PMID: 21118827. PMCID: PMC3046611. DOI: 10.1210/jc.2010-2704.
Vitamin D assays and the definition of hypovitaminosis D: results from the First International Conference on Controversies in Vitamin D
Published in British Journal of Clinical Pharmacology (2018).
Publication details
Sempos CT, Heijboer AC, Bikle DD, et al. Vitamin D assays and the definition of hypovitaminosis D: results from the First International Conference on Controversies in Vitamin D. British Journal of Clinical Pharmacology. 2018;84(10):2194-2207. DOI: 10.1111/bcp.13652.
Vitamin D Insufficiency and Epistemic Humility: An Endocrine Society Guideline Communication
Published in Journal of Clinical Endocrinology & Metabolism (2024).
Publication details
McCartney CR, McDonnell ME, Corrigan MD, Lash RW. Vitamin D Insufficiency and Epistemic Humility: An Endocrine Society Guideline Communication. Journal of Clinical Endocrinology & Metabolism. 2024;109(8):1948-1954. DOI: 10.1210/clinem/dgae322.